Pasithea Therapeutics Corp. Share Price
NASDAQ: KTTA | Micro CapPasithea Therapeutics Corp. Stock Performance
Open $0.57 | Prev. Close $0.56 | Circuit Range N/A |
Day Range $0.56 - $0.60 | Year Range $0.29 - $2.06 | Volume 4,500 |
Average Traded $0.59 |
Pasithea Therapeutics Corp. Share Price Today
As of 31 August 2026, Pasithea Therapeutics Corp.'s share price is $0.59. The stock opened at $0.57, compared to its previous close of $0.56. During today's trading session, Pasithea Therapeutics Corp.'s share price traded between $0.56 and $0.60, with an average price of $0.58. Over the past 52 weeks, the stock has recorded a high of $2.06 and a low of $0.29. In terms of performance, Pasithea Therapeutics Corp.'s share price has declined by 28.51% over the last six months and is down 27.72% on a year-on-year basis.
Pasithea Therapeutics Corp. Share Price Chart
Pasithea Therapeutics Corp. Stock Fundamentals & Key Indicators
Market Cap $4.12M | PE Ratio (TTM) -0.20 | Dividend Yield N/A |
EPS (TTM) $-2.91 | Revenue (TTM) N/A | Return On Equity (TTM) -36.99% |
Profit Margin N/A | Debt to Equity 0.09 | Quarterly Earnings Growth YoY -1.25% |
Pasithea Therapeutics Corp. Quarterly Profit & Loss
All figures in USD
Pasithea Therapeutics Corp. Annual Profit & Loss
All figures in USD
About Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp., a clinical-stage biotechnology company, focuses on the discovery, research, and development of treatments for central nervous system (CNS) disorders, RASopathies, and cancers. Its lead product candidate is PAS-004, a next-generation macrocyclic mitogen-activated protein kinase, or MEK inhibitor to treat a range of RASopathies, including neurofibromatosis type 1 (NF1); MAPK pathway-driven tumors, such as BRAFv600 and BRAF fusion tumors; and ETS2 driven diseases, including inflammatory bowel disease (IBD), primary sclerosing cholangitis, and ankylosing spondylitis. The company's lead development candidate is PAS-003, to treat amyotrophic lateral sclerosis. It also intends to develop PAS-001, to treat schizophrenia. Pasithea Therapeutics Corp. was incorporated in 2020 and is headquartered in Miami Beach, Florida.
Pasithea Therapeutics Corp. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $0.45 | $0.56 | +19.35% |
Jul 2026 | $0.59 | $0.47 | -9.36% |
Jun 2026 | $0.71 | $0.51 | -27.85% |
May 2026 | $0.72 | $0.71 | +0.71% |
Apr 2026 | $0.65 | $0.71 | -5.87% |
Mar 2026 | $0.83 | $0.75 | -8.42% |
Feb 2026 | $0.85 | $0.82 | -4.99% |
Jan 2026 | $1.23 | $0.86 | -33.69% |
Dec 2025 | $1.25 | $1.30 | -10.96% |
Nov 2025 | $0.82 | $1.46 | +82.27% |
Oct 2025 | $0.73 | $0.80 | +11.25% |
Sep 2025 | $0.81 | $0.72 | -11.11% |
KTTA Share Price FAQs
What is Pasithea Therapeutics Corp. share price today?
What is the 52 week high and 52 week low of Pasithea Therapeutics Corp. stock?
What is KTTA's market capitalisation today?
What is KTTA's net income for the last quarter?
What is the 5 year returns of KTTA?
What is the high & low stock price of KTTA today?
Can I buy KTTA shares in India?